Champions Oncology, Inc · Baltimore, MD United States (OTC: CSBR)
| 855 N. Wolfe St., Ste. 619 | Phone: 410-369-0365 |
| Baltimore, MD | Fax: 410-369-0390 |
| 21205 | |
| United States | 
Map This Company |
Champions Oncology, Inc Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Champions Oncology (formerly Champions Biotechnology) is hoping to win big in the field of cancer research. Its Champions Tumorgraft platform allows the company to implant human tumors of various cancer types into mice, allowing scientists to study the effects of investigational drugs on human cancers. The company uses the platform in its own research and also provides tumor-specific research to doctors, as well as the Tumorgraft platform to other drug developers. The company has licensed the rights to explore Irinophore, a nanoparticle in preclinical development.
Champions Oncology, Inc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: CSBR Headquarters |
|---|---|
| Fiscal Year-End | April |
| 2011 Employees | 18 |
Executives
11 executives listed for Champions Oncology, Inc's Baltimore, MD location.
| Chairman | David Sidransky | |
|---|---|---|
| CEO and Director | Joel Ackerman | |
| President and Director | Ronnie Morris |